Armata Pharmaceuticals Inc
AMEX:ARMP
Intrinsic Value
The intrinsic value of one ARMP stock under the Base Case scenario is 1.98 USD. Compared to the current market price of 1.59 USD, Armata Pharmaceuticals Inc is Undervalued by 20%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Armata Pharmaceuticals Inc
Fundamental Analysis

Revenue & Expenses Breakdown
Armata Pharmaceuticals Inc
Balance Sheet Decomposition
Armata Pharmaceuticals Inc
Current Assets | 11.3m |
Cash & Short-Term Investments | 9.3m |
Receivables | 744k |
Other Current Assets | 1.3m |
Non-Current Assets | 75.1m |
PP&E | 54.9m |
Intangibles | 13.7m |
Other Non-Current Assets | 6.5m |
Free Cash Flow Analysis
Armata Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Armata Pharmaceuticals Inc
Revenue
|
5.2m
USD
|
Operating Expenses
|
-47.6m
USD
|
Operating Income
|
-42.4m
USD
|
Other Expenses
|
23.5m
USD
|
Net Income
|
-18.9m
USD
|
ARMP Profitability Score
Profitability Due Diligence
Armata Pharmaceuticals Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
Score
Armata Pharmaceuticals Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
ARMP Solvency Score
Solvency Due Diligence
Armata Pharmaceuticals Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.
Score
Armata Pharmaceuticals Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ARMP Price Targets Summary
Armata Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ARMP is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.
Dividends
Current shareholder yield for ARMP is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one ARMP stock under the Base Case scenario is 1.98 USD.
Compared to the current market price of 1.59 USD, Armata Pharmaceuticals Inc is Undervalued by 20%.